| Financial Year |
March 31 2023 |
| Monetary Funds |
8,204,281,939.57 |
| Held-for-trading Financial Assets |
33,800,769.40 |
| Notes Receivable |
72,439,850.00 |
| Accounts Receivable |
5,262,752,511.07 |
| Advances to Suppliers |
525,834,287.37 |
| Other Receivables |
735,544,761.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
145,804,864.36 |
| Inventories |
2,010,610,766.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,100,000.00 |
| Other Current Assets |
848,906,444.69 |
| Total Current Assets |
18,468,800,440.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
333,885,031.82 |
| Long-term Equity Investment |
882,770,371.31 |
| Investment Properties |
-- |
| Fixed Assetes |
15,177,004,028.54 |
| Under-construction Projects |
3,562,506,357.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,345,553.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
59,645,561.65 |
| Deferred Income Tax Assets |
232,656,620.95 |
| Other Non-Current Assets |
294,856,570.05 |
| Sub-Total of Non-Current Assets |
22,409,642,189.50 |
| Total Assets |
40,878,442,630.20 |
| Short-Term Loans |
1,626,578,776.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,256,921,586.71 |
| Accounts Payable |
2,854,152,306.60 |
| Accounts Received In Advance |
2,305,227.12 |
| Employee Compensation Payable |
75,338,529.25 |
| Taxes Payable |
80,789,885.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
482,826,435.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,371,570,913.61 |
| Other Current Liabilities |
18,182,697.24 |
| Sub-Total of Current Liabilities |
10,004,360,905.27 |
| Long-term Loans |
5,599,105,877.97 |
| Bonds Payable |
2,671,035,312.56 |
| Long-Term Accounts Payable |
5,398,690,067.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,824,298.48 |
| Deferred Income Tax Liabilities |
172,913,890.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,339,128,353.70 |
| Total Liabilities |
25,343,489,258.97 |
| Paid-In Capital(Or Share Stock) |
3,570,883,411.00 |
| Capital Surplus |
8,577,892,250.56 |
| Surplus Reserve |
41,995,556.01 |
| LESS:Treasury Stock |
199,257,065.92 |
| Undistributed Profits |
2,970,537,744.65 |
| Minority Stockholder's Interest |
115,394,473.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,419,558,897.53 |
| Owner's Equity（Stockholder's Equity） |
15,534,953,371.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,878,442,630.20 |
